About Pyxant
Pyxant is a company based in Colorado Springs (United States) founded in 1984 was acquired by Aliri in June 2021. Pyxant has raised $4.03 million across 10 funding rounds from investors including Aliri. Pyxant has completed 1 acquisition, including Covance. Pyxant offers products and services including Bioanalytical Services, Method Development, Sample Analysis, and FDA Support. Pyxant operates in a competitive market with competitors including BioAgilytix, Advion, Tentamus, Nordic Bioscience and Alderley Analytical, among others.
- Headquarter Colorado Springs, United States
- SectorsHealthcare
- Website pyxant.com
- Social LinkedIn
- Acquired by Aliri (Jun 2021)
- Legal Name Pyxant Labs Inc.
Products & Services of Pyxant
Pyxant offers a comprehensive portfolio of products and services, including Bioanalytical Services, Method Development, Sample Analysis, and FDA Support.
Offers analytical research for drug discovery and clinical trials.
Develops and validates methods for compounds in biological matrices.
Conducts bioanalysis for various compound classes and tissues.
Assists with veterinary medicine and bioequivalence studies.
Funding Insights of Pyxant
Pyxant has successfully raised a total of $4.03M across 10 strategic funding rounds. The most recent funding activity was a Unspecified round of $1.1 million completed in July 2017. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $4.03M
- Total Rounds 10
- Last Round Unspecified — $1.1M
- First Round $480,000
(Aug 2002)
All 10 funding rounds of Pyxant with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul 2017 | $1.1M | Unspecified | – | – | – |
| Mar 2014 | $690,000 | Unspecified | – | – | – |
| Aug 2007 | $240,000 | Unspecified | – | – | – |
| May 2006 | $350,000 | Unspecified | – | – | – |
| Aug 2005 | $433,439 | Unspecified | – | – | – |
| Dec 2004 | $574,000 | Unspecified | – | – | – |
| Sep 2004 | $107,000 | Debt – Convertible | – | – | – |
| Jan 2004 | $500,000 | Debt – Conventional | – | – | – |
| Aug 2003 | $155,000 | Unspecified | – | – | – |
| Aug 2002 | $480,000 | Unspecified | – | – | – |
1 investors in total: 1 institutional.
Investors in Pyxant
Pyxant has secured backing from 1 investor. Prominent investors backing the company include Aliri.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
CRO focused on drugs discovery, method development, and validation services | 2009 | aliribio.com | Colorado Springs, United States |
Investor details for Pyxant
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Pyxant
Pyxant has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include Covance.
| Company Name | Description | Domain | Location | Founded | Acquired | Amount |
|---|---|---|---|---|---|---|
CRO offering comprehensive drug development solutions from drug discovery to life cycle management | covance.com | Princeton, United States | 1996 | May 2021 | •••• |
Complete acquisition details for Pyxant
Acquired stakes, deal sources and the complete acquisition history require an active premium plan.
- Acquired stakes
- Deal sources
- Complete history
- Exports
Verified entity values are shown only after access is granted.
Competitors of Pyxant
Pyxant operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as BioAgilytix, Advion, Tentamus, Nordic Bioscience and Alderley Analytical, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| bioagilytix.com | 2008 | Durham, United States | – | 446 | Large-molecule bioanalysis is provided for biologics and biosimilars development. | |
| advion.com | 1993 | Ithaca, United States | $45.64M | 54 | Microfluidics and mass spectrometry products are provided for clinical research. | |
| tentamus.com | 2011 | Berlin, Germany | – | 368 | Analytical and quality assurance services are provided for diverse industries. | |
| nordicbioscience.com | 1996 | Herlev, Denmark | – | 178 | Preclinical and clinical drug development CRO with proprietary in-house Biomarker platform | |
| alderleyanalytical.com | 2013 | Stockport, United Kingdom | $869,352 | 41 | Bioanalytical assays for drug development are developed and validated. | |
| eag.com | 1978 | San Diego, United States | – | 601 | Company offering a suite of scientific services for materials, engineering, agri, and life science industries | |
| nuvisan.com | 1979 | Neu Ulm, Germany | – | 1,011 | Clinical trial supply and bioanalytical services are provided globally. | |
| lightcast.bio | 2019 | Cambridge, United Kingdom | $107.09M | 25 | Advanced single-cell analysis solutions are provided for biotechnology research. | |
| apocell.com | 2004 | Houston, United States | – | 2,198 | Provider of clinical trial and clinical development on bioanalytical services | |
| solvias.com | 1999 | Kaiseraugst, Switzerland | – | – | Integrated R&D services are provided for pharmaceuticals and allied sectors. |
Detailed competitors of Pyxant
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Pyxant
Complete news archive for Pyxant
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Similar companies to Pyxant
10 companies that operate in the same segment as Pyxant (Biopharma Outsourcing & Drug Delivery), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Developer of integrated contract research development and manufacturing services | 2007 | Bengaluru, Karnataka, India | USD 35.74 M | USD 226.38 M | 1,820 | |
Drug discovery and development services are provided to biopharma sector. | 1993 | Hamburg, Hamburg, Germany | USD 25 M | USD 926.33 M | 4,830 | |
Drug discovery and development services for small molecules are provided. | 2003 | Beijing, China | USD 320 M | – | 476 | |
Suite solutions are provided for payers and healthcare providers. | 1998 | Princeton, New Jersey, United States | USD 255.15 M | USD 374.1 M | 4,490 | |
Wearable insulin infusion systems are developed for diabetes patients. | 2000 | Boston, Massachusetts, United States | USD 120.4 M | USD 2.71 B | 3,900 | |
Developer of small-molecule drugs | 1991 | Los Angeles, California, United States | USD 50 M | USD 348.97 M | 407 | |
Pharmaceutical and biotechnology company | 2005 | Hyderabad, Telangana, India | USD 229.73 M | USD 726.15 M | 12,470 | |
Pharmaceutical products for treating multiple diseases are provided. | 1849 | New York, New York, United States | USD 8 M | USD 266.99 M | 1,770 | |
Provider of laboratory tests for physicians | 1969 | Burlington, Vermont, United States | – | USD 13.95 B | 70,000 | |
India's leading healthcare products distribution platform | 2018 | Mumbai, Maharashtra, India | USD 59.67 M | USD 702.49 M | 4,260 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Pyxant
Pyxant was founded in 1984 and raised its 1st funding round 18 years after it was founded.
Pyxant is headquartered in Colorado Springs, United States. It is registered at Colorado Springs, Colorado, United States.
Pyxant is a funded company, having raised a total of $4.03M across 10 funding rounds to date. The company's 1st funding round was a Unspecified of $480K, raised on Aug 2002.
Pyxant Labs was established in 1984 in Colorado Springs, United States, as a contract research organization focused on the life sciences sector. GLP-compliant bioanalytical chemistry support is offered for drug development, including method development, validation, assay optimization, metabolism and toxicology analysis, sample preparation, and bioequivalence studies. A CLIA-certified clinical laboratory division handles assay services for patient specimens such as urine and oral fluids.
Pyxant's top competitors include Alderley Analytical, BioAgilytix and Lightcast Discovery.
Pyxant offers Bioanalytical Services, Method Development, Sample Analysis, and FDA Support.
Pyxant has made 1 acquisition, including Covance.
Pyxant has 1 investor. Key investors include Aliri.
Pyxant operates through Pyxant Labs Inc..
Yes. Pyxant was acquired by Aliri in June 2021.